Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

Celator Pharmaceuticals Inc.

Celator is a biopharmaceutical company working to develop new and more effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies designed to target cancer cells. The company’s lead product is in clinical development for the treatment of acute myeloid leukemia.

Investment year: 2003
Industry sector: Medical/health
Region: Atlantic
Website
Follow Celator Pharmaceuticals Inc.